DENTSPLY International Inc

Most Recent

  • uploads///checklist _
    Company & Industry Overviews

    How XRAY’s Performance Has Shaken Out over the Last Month

    Dentsply Sirona stock witnessed a steady uptick in November, rising from $34.58 on November 6 to $37.78 on November 30.

    By Kenneth Smith
  • uploads///XRAY
    Company & Industry Overviews

    What Does Dentsply’s Bottom-Line Trend Indicate?

    Dentsply Sirona’s interest expense decreased marginally from $9.8 million in the third quarter of 2017 to $9.7 million in the third quarter.

    By Kenneth Smith
  • uploads///STOCK PRICE
    Company & Industry Overviews

    Align Technology Traded at Its 52-Week High in September

    Align Technology was trading at its 52-week high of $398.88 on September 25. The stock reported its 52-week low of $180.31 on September 28, 2017.

    By Sarah Collins
  • uploads///recommendation
    Company & Industry Overviews

    Wall Street Analysts Are Still Bullish on ALGN Stock

    Align Technology (ALGN) stock hasn’t received any recommendation updates since the stock was upgraded by several analysts in July.

    By Sarah Collins
  • uploads///kyle sterk  unsplash
    Company & Industry Overviews

    ALGN Stock Surpasses the S&P 500 Index’s Year-to-Date Gain

    On September 28, Align Technology (ALGN) posted an ~74% increase year-to-date. In the same period, the S&P 500 Index has returned ~9%.

    By Sarah Collins
  • uploads///chair _
    Earnings Report

    Dentsply Sirona’s Segments: Q2 2018 Performance

    Since its second-quarter earnings release on July 7, Dentsply Sirona (XRAY) stock has plummeted ~20%.

    By Kenneth Smith
  • uploads///XRAY
    Earnings Report

    Gauging Dentsply Sirona’s Valuation Trend and Recent Acquisitions

    Dentsply Sirona (XRAY) has lowered its guidance for fiscal 2018. It expects adjusted EPS of $2–$2.15 compared to $2.55–$2.65 previously.

    By Kenneth Smith
  • uploads///dECLINES
    Company & Industry Overviews

    Top Losses: Cruise Operators Fell on June 5?

    Carnival, which is a US-based cruise company and the world’s largest travel leisure company, was the S&P 500’s top loss on June 5.

    By Val Kensington
  • uploads///RECOMMENDATIONS
    Company & Industry Overviews

    Word on the Street: Recommendations and Target Prices on ALGN

    Align Technology (ALGN) has reported a strong stock performance recently, with its stock price reaching a 52-week high on May 29.

    By Sarah Collins
  • uploads///smile _
    Company & Industry Overviews

    Align Technology Reported a 52-Week High on May 29

    Align Technology (ALGN) hosted its 2018 Investor Day on May 23. On the day, the company provided a variety of updates.

    By Sarah Collins
  • uploads///teeth _
    Company & Industry Overviews

    Align Technology: Analysts Raise Their Target Prices

    On May 25, Berenberg increased its 12-month target price on Align Technology (ALGN) from $312 to $340.

    By Sarah Collins
  • uploads///eps estimate
    Earnings Report

    Analysts Expect a Fall in Dentsply Sirona’s Adjusted Earnings

    Dentsply Sirona accounts for ~0.29% of the total holdings of the Vanguard Mid-Cap ETF. It’s set to release its 1Q18 results on May 7.

    By Sarah Collins
  • uploads///tooth _
    Earnings Report

    Analysts Cut Their Targets for XRAY ahead of Its 1Q18 Results

    Dentsply Sirona, one of the leading dental technology providers in the United States, will announce its 1Q18 earnings results on May 7.

    By Sarah Collins
  • uploads///STOCK PRICE
    Company & Industry Overviews

    Will Dentsply Sirona Stock Recover from Recent Declines?

    On April 6, 2018, Dentsply Sirona (XRAY) ended at a closing price of $49.02 per share.

    By Sarah Collins
  • uploads///leading position
    Company & Industry Overviews

    Why Barrington Research Cut Its Target Price on Dentsply Sirona

    On March 27, 2018, Barrington Research reiterated its “buy” rating on Dentsply Sirona (XRAY) while reducing its target price on the stock from $70 to $69.

    By Sarah Collins
  • uploads///recommendations
    Company & Industry Overviews

    What Wall Street Analysts Recommend for Dentsply Sirona

    Dentsply Sirona (XRAY), one of the leading dental technology providers in the United States, recently outlined a turnaround plan to recover from the company’s disappointing performance in recent years.

    By Sarah Collins
  • uploads///handshake _
    Company & Industry Overviews

    Dentsply Sirona to Acquire OraMetrix: What You Need to Know

    On March 26, 2018, Dentsply Sirona (XRAY) announced its plans to acquire OraMetrix.

    By Sarah Collins
  • uploads///PROJECTIONS
    Company & Industry Overviews

    Reading Dentsply Sirona’s Guidance for 2018

    For fiscal 2018, the company expects its sales to be in the range of $4.2 billion–$4.25 billion.

    By Sarah Collins
  • uploads///leading position
    Company & Industry Overviews

    Why Is Dentsply Sirona So Confident That It Can Gain Market Share?

    Although Dentsply Sirona has given a disappointing performance recently, the company is still confident that it can gain a higher market share going forward.

    By Sarah Collins
  • uploads///OPERATIONAL EXCELLENCE
    Company & Industry Overviews

    Here’s What Dentsply Sirona Has Planned for Its Margins

    Dentsply Sirona has a new management team that is working toward a more successful integration because it delivered lower-than-expected synergies in 2017.

    By Sarah Collins
  • uploads///ANNUAL LAUNCHES
    Company & Industry Overviews

    Why Innovation Matters to Dentsply Sirona—Now More Than Ever

    Dentsply Sirona has an industry-leading R&D budget with more than 600 scientists and engineers. The company invests $125 million per year on R&D.

    By Sarah Collins
  • uploads///growth opportunity
    Company & Industry Overviews

    The Key Factors in Dentsply Sirona Sales Growth Plan

    Dentsply Sirona (XRAY) has delivered lower merger synergies than the company had estimated. It also took an impairment charge during 4Q17.

    By Sarah Collins
  • uploads///TOP FIVE PRIORITIES
    Company & Industry Overviews

    Dentsply Sirona’s Top 5 Priorities for Executing a Strategic Business Turnaround

    With the recent transition in leadership at Dentsply Sirona (XRAY), the new team has laid out a robust strategic growth plan.

    By Sarah Collins
  • uploads///NEW SEGMENT STRUCTUR
    Company & Industry Overviews

    Understanding Dentsply Sirona’s New Organizational Structure

    In 4Q17, Dentsply Sirona (XRAY) started reporting its operations under two segments, after a shift to three segments in fiscal 3Q17.

    By Sarah Collins
  • uploads///NON GAAP RECONCILLIATION
    Company & Industry Overviews

    Behind Dentsply Sirona’s Total Impairment Charges in 2017

    Dentsply Sirona (XRAY) updated its estimates and assumptions during fiscal 2Q17 and underwent an annual impairment test of goodwill.

    By Sarah Collins
  • uploads///stock price
    Company & Industry Overviews

    Reading Dentsply Sirona’s Recent Stock Performance

    On March 13, 2018, Dentsply Sirona closed trading at a price of $57.80 per share. The stock registered its 52-week high of $68.98 on November 28, 2017.

    By Sarah Collins
  • uploads///peter kasprzyk  unsplash
    Company & Industry Overviews

    Why Is Wall Street Still Upbeat on Dentsply Sirona’s Growth Potential in 2018?

    Dentsply Sirona is a leading dental technology, equipment, and consumables provider in the US. But it has been going through some tough times.

    By Sarah Collins
  • uploads///SDC
    Company & Industry Overviews

    Align Technology and Its SmileDirectClub Partnership

    In 4Q17, Align Technology reported a sequential decline in its shipments of non-Invisalign SDC aligners to SDC.

    By Sarah Collins
  • uploads///teen and adult
    Company & Industry Overviews

    Increased Penetration in Teen Market Is Still Align’s Focus

    Every year, approximately 75% of Align Technology’s (ALGN) total orthodontic case starts are for teens.

    By Sarah Collins
  • uploads///SCANNER AND SERVICES Q AND FY
    Company & Industry Overviews

    Align’s iTero Scanner Was Strong Growth Driver in 2017

    In 4Q17, Align Technology (ALGN) reported $57.1 million in revenues from its scanner and services business.

    By Sarah Collins
  • uploads///Invisalign shipment trend
    Company & Industry Overviews

    Align Technology’s Invisalign: Average Selling Price and Volumes

    Increases in Align Technology’s (ALGN) Invisalign volumes and ASP were the major factors driving the company’s sales growth.

    By Sarah Collins
  • uploads///analyst recommendations
    Company & Industry Overviews

    Align Technology: Analyst Ratings and Recommendations

    Of the 12 investment research firms following ALGN stock, ten of them have given the stock “buy” or “strong buy” recommendations.

    By Sarah Collins
  • uploads///RECMMENDATIONS
    Company & Industry Overviews

    Wall Street Issues Majority ‘Buy’ Ratings on Align Technology

    On December 29, 2017, according to 12 investment brokerage firms which were part of a Reuters survey, Align Technology stock has received a “buy” rating from 11 analysts.

    By Sarah Collins
  • uploads///value chain
    Company & Industry Overviews

    Align Technology’s Customer Acquisition Strategy Driving Market Growth

    In 3Q17, Align Technology trained nearly 1,000 doctors in China.

    By Sarah Collins
  • uploads///NORTH AMERICA
    Company & Industry Overviews

    ALGN Terminates 3Shape TRIOS’s Invisalign Interoperability Contract

    On December 20, 2017, Align Technology announced the termination of its Invisalign interoperability contract with 3Shape.

    By Sarah Collins
  • uploads///MARKET OPPORTNITY
    Company & Industry Overviews

    Align Technology’s Growth Prospects amid Increasing Competition

    The Chinese market is Align Technology’s major growth driver. However, the company is starting to witness strong competition from startups focused on the clear aligners market.

    By Sarah Collins
  • uploads///Graph
    Company & Industry Overviews

    Behind Align Technology’s Key Growth Driver in 2017

    In 3Q17, Align Technology’s (ALGN) Invisalign case volumes shipped to doctors in international markets rose 47.4% on a YoY basis and 6.8% sequentially.

    By Margaret Patrick
  • uploads///leading portfolio
    Company & Industry Overviews

    Developments in Dentsply Sirona’s Digital Dentistry Portfolio

    On September 20, 2017, Dentsply Sirona (XRAY) announced an enhancement to its Galileos Implant software.

    By Sarah Collins
  • uploads///MATRX PLUS PATIENT JOURNEY
    Company & Industry Overviews

    Dentsply Sirona’s Dental Sleep Medicine and a Recent Partnership

    Dentsply Sirona (XRAY) and Zephyr Sleep Technologies have entered into a strategic partnership for the treatment of OSA (obstructive sleep apnea).

    By Sarah Collins
  • uploads///recommendations
    Company & Industry Overviews

    What Analysts Are Recommending for Dentsply Sirona

    According to the recommendations of 15 brokerage firms, 60.0% (or nine) of them have rated Dentsply Sirona (XRAY) a “buy,” and 33.0% (or five) have rated it a “hold.”

    By Sarah Collins
  • uploads///leading portfolio
    Company & Industry Overviews

    Dentsply Sirona’s Newly Launched Cerec Zirconia Meso Block

    In August 2017, Dentsply Sirona (XRAY) launched its Cerec Zirconia Meso Block for creating customized screw-retained crowns.

    By Sarah Collins
  • uploads///recommendations
    Company & Industry Overviews

    What Do Analysts Recommend for Dentsply Sirona?

    Based on the recommendations of 16 brokerage companies, around 63% (or ten) of the analysts provided a “buy” recommendation for Dentsply Sirona.

    By Sarah Collins
  • uploads///stock price
    Company & Industry Overviews

    Discussing Dentsply Sirona’s Recent Stock Performance

    Dentsply Sirona (XRAY) closed at $55.30 on August 11, 2017. The company was trading at its 52-week low of $54.50 on the day.

    By Sarah Collins
  • uploads///REVENUES BY SEGMENT
    Company & Industry Overviews

    Dentsply Sirona’s Technologies Segment Sales Declined in 2Q17

    In 2Q17, Dentsply Sirona’s (XRAY) Technologies business contributed ~44% to the company’s total revenues and registered sales of ~$439 million.

    By Sarah Collins
  • uploads///PROJECTIONS
    Company & Industry Overviews

    Discussing Dentsply Sirona’s Updated 2017 Guidance

    Dentsply Sirona made a downward revision to its fiscal 2017 guidance during the company’s 2Q17 earnings results announcement on August 9, 2017.

    By Sarah Collins
  • uploads///REVENUES BY SEGMENT
    Company & Industry Overviews

    Dental and Healthcare Consumables Grew but Missed Expectations in 2Q17

    In 2Q17, Dentsply Sirona’s (XRAY) Dental and Healthcare Consumables business contributed ~56% to the company’s total revenues and registered sales of ~$554 million.

    By Sarah Collins
  • uploads///EPS estimates
    Company & Industry Overviews

    Dentsply Sirona’s 2Q17 Results: Key Highlights

    Dentsply Sirona (XRAY) reported its 2Q17 earnings on August 9. The company earned revenues of ~$992.7 million, registering a year-over-year decline of ~2.9%.

    By Sarah Collins
  • uploads///Graph
    Company & Industry Overviews

    Align Technology Focuses on International Market Strategy

    International market strategy In 2Q17, Align Technology (ALGN) reported 85,400 Invisalign case shipments in international markets, which is YoY (year-over-year) growth of ~37.4% and sequential growth of ~13.6%. This growth was mainly attributed to new customers in the EMEA (Europe, the Middle East, and Africa) and Asia-Pacific markets. If Align Technology continues to demonstrate solid […]

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Analysts’ Recommendations for Align Technology in August 2017

    Of the 13 analysts covering Align Technology in August 2017, eight rated the company a “strong buy,” and five rated it a “buy.”

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Inside Align Technology’s Market Expansion Strategy

    In 1Q17, Align Technology (ALGN) also witnessed a robust rise of around 45.2% in volumes of Invisalign sold in Asia-Pacific markets on a YoY basis.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Understanding Align Technology’s Growing Position in International Markets

    In 1Q17, Align Technology (ALGN) witnessed an 11.4% sequential rise in the volume of Invisalign cases used by doctors in international markets.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    These Are Align Technologies Key Demand Drivers in North America

    In 1Q17, Align Technology (ALGN) has started selling its new product Invisalign Go in North America, which involves a few DSOs (dental service organizations).

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Behind Align Technology’s North American Expectations for 2017

    In 1Q17, Align Technology’s (ALGN) Invisalign sales volumes in North American markets rose YoY by 20.3% and QoQ by 8.3%.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Inside Align Technology’s Robust Revenue Growth Projection for 2017

    For fiscal 2017, Align Technology (ALGN) expects its 2017 revenues to grow operationally in the range of 15%–25% YoY.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Why Align Technology’s Orthodontics Is a Solid Growth Opportunity in 2017

    Align Technology (ALGN) is a medical device provider focused on malocclusion or teeth misalignment condition.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Align Technology versus Peers in June 2017: Analyst Recommendations

    For 1Q17, Align Technology (ALGN) reported revenues close to $310.3 million, which represents YoY (year-over-year) growth of around 30.0%.

    By Margaret Patrick
  • uploads///revenues by segment
    Earnings Report

    Dentsply Sirona’s New Growth Strategy to Accelerate Digital Dentistry Penetration

    Dentsply Sirona is the largest dental equipment and solutions manufacturer in the United States. Digital dentistry is a megatrend in the market.

    By Sarah Collins
  • uploads///product segments
    Earnings Report

    What Dragged Down Technology Business Sales in 1Q17?

    Dentsply Sirona’s Technology segment sales Dentsply Sirona (XRAY) reported ~$900 million of revenues worldwide in 1Q17. Of that, ~$389 million was generated through Dentsply Sirona’s Technology segment, which contributed ~43.2% to Dentsply Sirona’s total revenues. On a constant currency basis, the Technology segment’s sales declined by approximately 8.1%. The segment’s sales were flat in Europe. The […]

    By Sarah Collins
  • uploads///profitability
    Earnings Report

    How Dentsply Sirona’s Profitability Metrics Looked in 1Q17

    Dentsply Sirona’s (XRAY) 1Q17 earnings and revenue failed to meet analysts’ estimates. The company reported a fall in its organic revenue.

    By Sarah Collins
  • uploads///danaher adjusted earnings per share
    Earnings Report

    Danaher Stock Jumps as EPS Grows 22.5% on Margin Expansion

    Danaher (DHR) reported adjusted EPS of $0.87, which beat consensus estimates by $0.05. In growth terms, the adjusted EPS was 22.5% YoY.

    By Shannon Black
  • uploads///part
    Earnings Report

    Danaher to Declare Its First Earnings after Fortive Separation

    Danaher Corporation (DHR), which became a diversified healthcare company after its restructuring actions, is slated to declare its 3Q16 earnings on October 20. The consensus Wall Street estimate is for Danaher to post adjusted EPS of $0.83 on sales of ~$4.1 billion.

    By Shannon Black
  • uploads///danaher dental margins
    Company & Industry Overviews

    Danaher’s Dental Unit Putting Shine on Teeth and Profits

    Danaher’s Dental segment remained virtually unchanged when the company split its industrial businesses into the independent public company Fortive.

    By Shannon Black
  • uploads///danaher dental sales
    Company & Industry Overviews

    Danaher’s Dental Unit Enjoys These Competitive Advantages

    Danaher’s Dental segment is a $2.7 billion business.

    By Shannon Black
  • uploads///TECHNOLOGIES
    Earnings Report

    A Brief Look at the Technologies Segment Sales in 2Q16

    In 2Q16, Dentsply Sirona’s leading position in the Digital Sensor category and rebound in the Lab business drove its Technologies segment sales.

    By Sarah Collins
  • uploads///analyst recommendations
    Healthcare

    What Are Analysts’ Recommendations for Dentsply Sirona?

    According to a Bloomberg survey, 43% of the analysts gave Dentsply Sirona a “buy” rating and ~57% gave it a “hold” rating. It didn’t have any “sell” ratings.

    By Sarah Collins
  • uploads///combined business profile
    Healthcare

    Why Is Dentsply Sirona Acquiring MIS Implants?

    Dentsply Sirona is acquiring MIS due to its established brand and broad portfolio of implants and related products.

    By Sarah Collins
  • uploads///TECHNOLOGIES
    Company & Industry Overviews

    A Look at Dentsply Sirona’s Technologies Segment

    Dentsply Sirona’s (XRAY) technologies segment’s sales represented ~47% of the company’s total sales in 2015.

    By Sarah Collins
  • uploads///dental and healthcare consumables
    Company & Industry Overviews

    Exploring XRAY’s Dental and Healthcare Consumables Businesses

    Dentsply Sirona’s consumables products segment is responsible for the manufacture, distribution, and sale of dental products.

    By Sarah Collins
  • uploads///product portfolio
    Company & Industry Overviews

    A Brief Look at Dentsply Sirona’s Business Model

    Dentsply Sirona (XRAY) offers a broad portfolio of dental equipment and consumables that have urological and surgical applications.

    By Sarah Collins
  • uploads///combined business profile
    Company & Industry Overviews

    Introducing Dentsply Sirona, a Leading Dental Products Manufacturer

    Dentsply Sirona (XRAY) is the largest manufacturer of dental equipment and technologies in the world. The company was formed in February 2016.

    By Sarah Collins
  • uploads///Part  Graph
    Company & Industry Overviews

    Chinese Trade Numbers Fall for 16th Straight Time: Effect on XLV

    Chinese exports fell 25.4% on a year-over-year basis, and imports fell 13.8%, marking the 16th straight monthly decline. XLV fell 1.2% yesterday in response to the news.

    By Peter Neil
  • uploads///Graph Part  Nov
    Company & Industry Overviews

    Patterson Reports Fiscal 2Q16 Earnings, Drags Down Mid-Caps

    Patterson Companies (PDCO) fell 6% on its lower-than-expected fiscal 2Q16 results. Investors were disappointed with increasing operating expenses.

    By Peter Neil
  • uploads///pdco pe
    Earnings Report

    How Does Patterson Companies Compare to Its Peers?

    The respective PE ratios of Patterson Companies and peers Henry Schein, DENTSPLY International, and VCA are 23.6x, 27.1x, 31.5x, and 25.9x as of November 24.

    By Gabriel Kane
  • uploads///Graph Part  Nov
    Company & Industry Overviews

    How PerkinElmer Topped the XLV’s Mid-Cap Stocks

    At the Stifel 2015 Healthcare Conference, PerkinElmer presented its current position as well as its future growth and strategies for different markets.

    By Peter Neil
  • uploads///xray pbv
    Earnings Report

    How Does Dentsply International Compare to Peers after 3Q15?

    In this article, we’ll compare Dentsply against its peers and the ETFs that invest in Dentsply.

    By Gabriel Kane
  • uploads///cmn npm
    Earnings Report

    How Does Cantel Medical Compare to Its Peers?

    Cantel Medical outperformed its peers based on the net profit margin, current ratio, PE ratio, and PBV ratio. It outperformed its ETFs based on the PBV ratio.

    By Gabriel Kane
  • uploads///cmn pm
    Earnings Report

    Cantel Medical’s Revenue and Income Rose in 4Q15

    Cantel Medical reported net revenue of $151.255 million in 4Q15—a rise of 6.88% compared to the net revenue of $141.508 million in 3Q15.

    By Gabriel Kane
  • uploads///Graph Part
    Company & Industry Overviews

    Patterson Companies Was XLV’s Worst Performer

    Patterson Companies was the worst performer within the Health Care Select Sector SPDR ETF (XLV) for the period between August 25 and August 31, with a return of -4.10%.

    By Peter Neil
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.